Bio-Techne TECH Debt Repayments
Debt Repayments at other companies
Other financials
Where this comes from
Reported directly by Bio-Techne in its filing.
Tagged under the XBRL concept us-gaap:RepaymentsOfLinesOfCredit.
The official record: Bio-Techne’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bio-Techne's debt repayments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bio-Techne's debt repayments?
- Bio-Techne (TECH) reported debt repayments of $60M in Q1 2026.
- How has Bio-Techne's debt repayments changed year-over-year?
- Bio-Techne's debt repayments increased by 650.0% year-over-year, from $8M to $60M.
- What is the long-term trend for Bio-Techne's debt repayments?
- Over 4 years (2021 to 2025), Bio-Techne's debt repayments has grown at a -27.0% compound annual growth rate (CAGR), from $271.5M to $77M.
- What does debt repayments mean?
- Cash used to pay down borrowed debt.
- How do you interpret debt repayments?
- Higher repayments indicate a focus on reducing leverage and interest expense, while lower repayments may suggest a preference for holding cash or reinvesting.
- How does debt repayments compare across companies?
- Commonly monitored by investors to assess balance sheet health and interest rate sensitivity.